Covered recipient · General Payments record
ANDREEA OLARU
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$559.77
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.69 | 16 |
| Education | $65.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $121.56 | 6 |
| Astellas Pharma US Inc | $80.42 | 2 |
| Amgen Inc. | $59.51 | 2 |
| Lilly USA, LLC | $55.91 | 3 |
| Exact Sciences Corporation | $49.00 | 2 |
| DEXCOM, INC. | $20.11 | 1 |
| PFIZER INC. | $16.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $30.74 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111665460 | CMS |
| Amgen Inc. | $28.77 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111665462 | CMS |
| Astellas Pharma US Inc | $14.43 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139285948 | CMS |
| Astellas Pharma US Inc | $65.99 | 03/05/2024 | Education | Undisputed | 01/23/2026 | 1139345392 | CMS |
| Dexcom, Inc. | $20.11 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279305 | CMS |
| Exact Sciences Corporation | $22.17 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114815782 | CMS |
| Exact Sciences Corporation | $26.83 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114815787 | CMS |
| Lilly USA, LLC | $23.89 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136037429 | CMS |
| Lilly USA, LLC | $16.46 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136048271 | CMS |
| Lilly USA, LLC | $15.56 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136037427 | CMS |
| Novo Nordisk Inc | $18.07 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097205071 | CMS |
| Novo Nordisk Inc | $16.20 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097389354 | CMS |
| Novo Nordisk Inc | $20.62 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097606156 | CMS |
| Novo Nordisk Inc | $14.87 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097061462 | CMS |
| Novo Nordisk Inc | $27.57 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096587284 | CMS |
| Novo Nordisk Inc | $24.23 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096578385 | CMS |
| PFIZER INC. | $16.17 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131204692 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.